Cholecalciferol/Raloxifene

่ƒ†้ชจๅŒ–้†‡/้›ทๆด›ๆ˜”่Šฌ

Report date: 2024/04/08 20:04:57

Base Information

Drug NameCholecalciferol/Raloxifene
Drug Alias NameRaloxifene Hydrochloride/Colecalciferol่ƒ†้ชจๅŒ–้†‡+้›ทๆด›ๆ˜”่ŠฌRaloxifene Hydrochloride+Colecalciferol้›ทๆด›ๆ˜”่Šฌ/่ƒ†้ชจๅŒ–้†‡็›้…ธ้›ทๆด›ๆ˜”่Šฌ+่ƒ†้ชจๅŒ–้†‡ +[11]ย 
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptors modulatorsVitamin D receptor agonistsLysine-specific histone demethylase 1 inhibitors
TargetsEstrogen receptorsVitamin D receptorLysine-specific histone demethylase 1
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes ColecalciferolRaloxifene Hydrochloride
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAddpharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddpharma IncAlvogen Korea
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A